Importance Preexisting noncommunicable diseases (eg, diabetes) increase the risk of
COVID-19 infection, hospitalization, and death. Mood disorders are associated with impaired …

Following recovery from COVID-19, an increasing proportion of individuals have reported the
persistence and/or new onset of symptoms which collectively have been identified as post-…

Importance COVID-19 is associated with clinically significant symptoms despite resolution
of the acute infection (ie, post-COVID-19 syndrome). Fatigue and cognitive impairment are …

Ketamine is a promising therapeutic option in treatment-resistant depression (TRD). The
acute efficacy of ketamine in TRD has been demonstrated in replicated randomised-controlled …

Background A considerable proportion of individuals report persistent, debilitating and
disparate symptoms despite resolution of acute COVID-19 infection (ie long COVID). Numerous …

There is a need for innovation with respect to therapeutics in psychiatry. Available evidence
indicates that the trace amine-associated receptor 1 (TAAR1) agonist SEP-363856 is …

The emerging roles of ketamine and esketamine as effective rapid-acting antidepressants
hold promise for patients suffering from treatment-resistant depression and/or major …

Anhedonia is a common, persistent, and disabling condition. However, available therapeutics
primarily focus on the reduction of depressive and negative symptoms rather than …

Background Attention-deficit/hyperactivity disorder (ADHD) is associated with a broad range
of deficits in cognitive functions which has significant implications for quality of life. …

Empirical evidence addressing the association between SARS-CoV-2 vaccination and long
COVID would guide public health priorities and inform personal health decisions. Herein, …